David W. Morris

ORCID: 0009-0001-3656-5949 · 3 papers in corpus
rct 2001
·doi:10.1097/00006254-200104000-00018

Abstract Objective: To determine if sertraline is helpful in the management of depressive symptoms associated with ovarian suppression during GnRH agonist therapy as compared with a placebo-controlled group. Design: Double-blind placebo-con…

review 1998
Depression and anxiety ·doi:10.1002/(sici)1520-6394(1998)7:4<171::aid-da5>3.0.co;2-d

The gonadotropin-releasing hormone (GnRH) agonists are a relatively new class of drugs that are potentially effective in treating disorders that are aggravated either by estrogen or testosterone. GnRH agonists are effective in the treatment…

nonrandomized-trial 1998
Biological psychiatry ·doi:10.1016/s0006-3223(97)00396-x

BACKGROUND: Endometriosis is thought to affect 5-10% of reproductive age women in the general population and is commonly treated with gonadotropin-releasing hormone (GnRH) agonists. Recent studies suggest depressive symptoms are associated …